1. Nanoadjuvants Produced by Advanced Nanochelating Technology in the Inactivated-Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine Formulation: Preliminary Results on Cytokines and IgG Responses
   Somayeh Kalanaky et al, 2023, Viral Immunology CrossRef
2. Th17 CD4+ T-Cell as a Preferential Target for HIV Reservoirs
   Constance Renault et al, 2022, Frontiers in Immunology CrossRef
3. Changes in the balance of Th17/Treg cells and oxidative stress markers in patients with HIV‑associated pulmonary tuberculosis who develop IRIS
   Long Wen et al, 2023, Experimental and Therapeutic Medicine CrossRef